Peripheral Blood WT1 Expression Predicts Relapse in AML Patients Undergoing Allogeneic Stem Cell Transplantation

Figure 1

(a) OS of the 24 AML patients according to PB-WT1 level before allo-SCT. (b) LFS of the 24 AML patients according to PB-WT1 level before allo-SCT.

(a)

(b)